# Effect of Metformin on Breast Cancer Metabolism

> **NCT01266486** · PHASE2 · COMPLETED · sponsor: **Oxford University Hospitals NHS Trust** · enrollment: 41 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01266486
- **Lead sponsor:** Oxford University Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2014-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01266486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01266486, "Effect of Metformin on Breast Cancer Metabolism". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01266486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*